A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2014
At a glance
- Drugs Tolvaptan (Primary)
- Indications Congenital heart defects; Heart failure
- Focus Pharmacokinetics
- 31 Mar 2014 Status changed from not yet recruiting to completed according to the results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 16 Nov 2011 New trial record